Virtual Reality In Healthcare Market Size and Share

Virtual Reality In Healthcare Market Analysis by Mordor Intelligence
The Virtual Reality in Healthcare market size is expected to grow from USD 5.15 billion in 2025 to USD 6.51 billion in 2026 and is forecast to reach USD 20.99 billion by 2031 at 26.39% CAGR over 2026-2031. Growing institutional confidence, clearer reimbursement pathways, and falling hardware costs are converging to accelerate adoption. Hardware continues to anchor most revenues, yet content-rich software platforms are scaling faster as clinical validation and AI integration expand therapeutic scope. Early reimbursement decisions for FDA-authorized devices are already reshaping purchaser economics, and immersive delivery modes are proving especially effective for pain management, mental health, and rehabilitation. While cybersickness and privacy risks persist, targeted engineering improvements, risk-management frameworks, and stronger data-security standards are steadily mitigating these barriers.
Key Report Takeaways
- By component, hardware held 61.58% of the Virtual Reality in Healthcare market share in 2025, while software is advancing at a 28.48% CAGR through 2031.
- By application, surgery simulation and training led with 32.10% revenue share in 2025; rehabilitation and physical therapy is forecast to expand at a 28.96% CAGR to 2031.
- By end user, hospitals and clinics commanded 55.05% of the Virtual Reality in Healthcare market size in 2025, and rehabilitation centers record the fastest projected CAGR at 29.35% through 2031.
- By delivery mode, immersive VR captured 68.10% share of the Virtual Reality in Healthcare market in 2025 and is growing at a 29.70% CAGR toward 2031.
- By geography, North America dominated with 42.85% share in 2025, while Asia-Pacific is poised for the highest CAGR at 30.05% through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Market Trends and Insights
Drivers Impact Analysis of Virtual Reality In Healthcare Market*
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising adoption of VR for surgical training & simulation | +6.8% | Global, with early adoption in North America & Europe | Medium term (2-4 years) |
| Growing demand for pain management & mental-health therapies | +7.2% | Global, particularly strong in North America | Short term (≤ 2 years) |
| Technology cost reductions and improved hardware | +5.4% | Global, with manufacturing benefits in APAC | Long term (≥ 4 years) |
| Expansion of telemedicine integrating VR | +4.1% | North America & EU, expanding to APAC | Medium term (2-4 years) |
| Government reimbursement pilots for VR digital therapeutics | +5.9% | North America & EU, with CMS leading adoption | Short term (≤ 2 years) |
| Spatial-AI analytics enabling outcome-based rehabilitation | +3.8% | Global, with advanced healthcare systems leading | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Rising Adoption of VR for Surgical Training & Simulation
Surgical education is shifting from observation to experiential skill building. Randomized trials in 2024 confirmed that virtual procedures improved accuracy and shortened learning curves at leading U.S. teaching hospitals. Several surgical teams successfully deployed Apple Vision Pro headsets during live cases, proving intraoperative viability and sparking demand for device-agnostic, sterile-field-ready apps. Platform vendors now bundle haptic controllers and AI-guided assessment dashboards that score performance and feed data into credentialing systems. Pharmaceutical firms are joining the ecosystem by commissioning custom extended-reality modules that teach drug administration protocols alongside operative steps. Hospital networks that form “spatial computing centers of excellence” report faster staff onboarding and lower per-resident training costs, underscoring a business case that is forcing laggard institutions to reassess investment priorities[1]Source: U.S. Department of Veterans Affairs, “Immersive Virtual Reality in Health Care Literature Compendium,” va.gov .
Growing Demand for Pain Management & Mental-Health Therapies
A sharp policy pivot toward non-pharmacological pain relief, driven by the opioid crisis, has lifted virtual analgesia into mainstream care. FDA-authorized systems such as RelieVRx demonstrated durable pain reduction in almost 70% of patients 18 months after therapy, prompting the Centers for Medicare & Medicaid Services to activate three HCPCS codes that reimburse digital mental-health devices from January 2025. Academic medical centers now pair VR mindfulness modules with biofeedback sensors, and early real-world evidence indicates improved adherence compared with mobile-app counterparts. AI-powered therapy companions analyze gaze, voice, and physiologic data to adjust scene intensity in real time, broadening access for diverse socioeconomic groups and minimizing clinician workload.
Technology Cost Reductions and Improved Hardware
Component standardization, mass-market optics, and spatial-computing chipsets are compressing headset price points. Hospitals that once paid five-figure sums for specialized rigs now pilot consumer-grade devices for bedside education and remote consultations. Research shows smartphone-based VR kits deliver comparable pain-reduction scores to premium systems in low-acuity settings, offering budget-constrained facilities a workable entry path. Advances in lens design and motion-prediction algorithms are cutting cybersickness incidence, while modular hygiene sleeves and rapid-wipe materials simplify infection control. Haptic gloves with micro-pneumatic feedback are reaching FDA-listed status, opening new therapeutic modalities for fine-motor rehabilitation.
Expansion of Telemedicine Integrating VR
Immersive tele-presence is extending specialist expertise to rural patients without expensive brick-and-mortar expansion. Large U.S. health systems report that virtual nursing pilots reduce average discharge times by 15% and lift patient-satisfaction scores. Tele-rehabilitation suites combine motion-capture analytics with remote physical-therapist oversight, letting stroke survivors complete gamified exercise regimens at home. Regulatory bodies now treat many VR sessions as parity equivalents to in-person visits, provided data flow remains HIPAA-compliant. As 35% of global telehealth platforms embed AI decision support, demand for add-on VR modules that visualize anatomy or simulate exposure therapy is accelerating[2]Source: HealthManagement.org, “The Future of Telehealth,” healthmanagement.org .
Restraints Impact Analysis of Virtual Reality In Healthcare Market*
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High upfront hardware & integration costs | -3.2% | Global, particularly impacting smaller healthcare facilities | Short term (≤ 2 years) |
| Data-privacy & cybersecurity concerns | -2.8% | Global, with stricter regulations in EU and North America | Medium term (2-4 years) |
| Clinician cyber-sickness & ergonomic fatigue | -2.1% | Global, affecting healthcare worker adoption | Short term (≤ 2 years) |
| Fragmented device-certification pathways | -1.9% | Global, with varying regulatory frameworks by region | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
High Upfront Hardware & Integration Costs
Smaller providers struggle to fund capital purchases, staff training, and EHR integration simultaneously. Although baseline headset prices are falling, medical-grade add-ons such as sterilizable face cushions, 3D tracking cameras, and FDA-cleared haptic controllers keep bills elevated. Software licensing typically follows annual per-seat models that can rival the hardware cost within three years. Many administrators still lack clear return-on-investment templates, especially for non-reimbursed use cases like staff wellness or patient distraction during phlebotomy. Grants and pilot subsidies help, but sustained scaling often hinges on value-based contracts that share savings from reduced readmissions or opioid prescriptions.
Data-Privacy & Cybersecurity Concerns
Immersive systems capture biometric telemetry, gaze vectors, and contextual audio, adding new dimensions to protected health information. Regulators require granular consent and strong encryption, yet many off-the-shelf apps default to consumer-grade data handling. Recent threat assessments highlight risks of man-in-the-room attacks where unauthorized avatars impersonate clinicians during remote sessions. Hospitals are responding with zero-trust architectures, air-gapped VR networks, and real-time anomaly detection, but solution complexity raises deployment costs and slows procurement cycles.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Virtual Reality In Healthcare Market Segment Analysis
By Component:
Software Momentum Builds on a Solid Hardware BaseHardware accounted for 61.58% of 2025 revenue, underscoring its foundational role in the Virtual Reality in Healthcare market. Global headset shipments to hospitals rose sharply after vendors optimized optical stacks for prolonged clinical wear and rolled out plug-and-play sterilization kits. Gesture tracking and force-feedback peripherals are spreading from orthopedics into cardiology and endoscopy training programs. The Virtual Reality in Healthcare market size for software, while smaller today, is compounding at 28.48% annually as hospitals pivot to content subscriptions, AI-driven progress dashboards, and cloud-rendered multi-user scenarios. Regulatory-grade software development kits now ship with pre-filled documentation templates that speed FDA submissions, shortening time-to-revenue for independent developers.
Service revenues lag the two core segments yet remain vital. Health systems increasingly outsource design of VR skills-labs, endpoint provisioning, and cross-platform content curation. Consultants bundle change-management workshops that teach clinicians how to embed VR protocols in existing care pathways, strengthening long-term customer lock-in and boosting recurring revenues as software refresh cycles accelerate.

By Application:
Rehabilitation Accelerates Past Training Growth RatesSurgery simulation retained 32.10% share in 2025, with deployments in orthopedics, neurosurgery, and minimally invasive specialties continuing to expand. The Department of Veterans Affairs highlighted strong evidence for VR rehearsal boosting procedural confidence in novice surgeons. Meanwhile, rehabilitation and physical therapy captured payer attention after studies showed 20% faster gait-speed recovery for stroke survivors who engaged in immersive balance tasks. The Virtual Reality in Healthcare market size tied to rehabilitation is therefore scaling swiftly in absolute dollars despite its smaller base. FDA-authorized pain treatment modules further blur boundaries between rehab and chronic-pain care.
Medical education apps are diversifying into nursing, pharmacy, and emergency medicine, signaling broader curricular adoption. Patient-care-management tools, including exposure therapy and perioperative anxiety reduction modules, are winning grants aimed at lowering sedative use. Application developers who combine evidence generation with robust analytics dashboards gain an edge, because hospitals must demonstrate measurable functional gains to secure ongoing reimbursement.
By End User:
Rehabilitation Centers Close the GapHospitals and clinics still generate 55.05% of market revenue, reflecting their multi-modality focus on training, therapy, and patient education. Yet dedicated rehabilitation centers are posting a 29.35% CAGR as immersive platforms prove especially effective for neuro and ortho recovery. Home-based programs supplied by rehabilitation providers further expand the addressable pool of patients.
Academic and research institutes remain key influencers, leveraging grant funding to validate new protocols and publish outcome data that underpins reimbursement bids. Diagnostic centers are experimenting with VR to ease patient anxiety during procedures such as MRI or colonoscopy, reporting improved throughput and reduced need for sedatives. The Virtual Reality in Healthcare market share from these smaller segments is modest but strategically important, because positive patient experience scores help persuade insurers to authorize broader rollouts.

By Delivery Mode:
Immersive VR Sets the PaceImmersive systems delivered 68.10% of 2025 revenue and will sustain a 29.70% CAGR through 2031. Clinical trials consistently show that full sensory immersion boosts pain-distraction efficacy and movement learning by creating presence and focus. Semi-immersive setups, often displayed on wrap-around monitors, support group rehabilitation or patient education classes where clinician oversight is essential.
Non-immersive desktop or tablet solutions remain relevant for low-risk instruction but cannot match clinical outcomes demonstrated by head-worn devices. Developers consequently front-load R&D into immersive pipelines, and component suppliers chase higher-resolution micro-OLED panels, lighter counter-balanced frames, and longer battery life.
Geography Analysis
North America Virtual Reality In Healthcare Market
North America controlled 42.85% of 2025 revenue, supported by a proactive FDA that issued a dedicated 21 CFR code for VR behavioral-therapy devices and a Transitional Coverage for Emerging Technologies rule that accelerates Medicare payments. Large integrated-delivery networks budget for immersive technology labs and continually feed outcome data to payers, reinforcing virtuous adoption cycles. Insurers in the region now review VR claims under durable-medical-equipment criteria, giving providers a clearer cost-recovery path.
Europe Virtual Reality In Healthcare Market
Europe follows with steady uptake driven by public-sector pilots and cross-border research consortia. Compliance with the EU’s General Data Protection Regulation shapes system design, fostering robust security architectures that are becoming global blueprints. Germany’s hospital-funding reforms in 2025 earmarked capital for digital therapeutics, and France’s national health authority published clinical-practice guidelines that recommend VR analgesia for certain chronic-pain cohorts.
APAC Virtual Reality In Healthcare Market
Asia-Pacific is the fastest-growing region, posting a 30.05% CAGR. Local electronics supply chains trim headset bills, while government grants encourage rural tele-rehabilitation. Japan’s aging population fuels demand for fall-prevention programs, and Australia’s national insurance scheme has begun reimbursing VR chronic-pain modules for eligible patients. The Virtual Reality in Healthcare market size across APAC is therefore projected to surpass European totals earlier than once anticipated.
South America and MEA Virtual Reality In Healthcare Market
South America and the Middle East & Africa are smaller today but gaining momentum. Brazilian private hospitals deploy VR for pediatric oncology distraction, and Gulf states include immersive simulation centers in new medical-city master plans. Partnerships with global OEMs and university research hubs are accelerating technology transfer, bypassing legacy barriers that once slowed digital-health adoption.

Regulatory Landscape
Regulation for VR in healthcare continues to crystallize around medical-device and digital-health frameworks rather than as a standalone VR regime. In the United States, the FDA Digital Health Center of Excellence maintains a public Augmented Reality and Virtual Reality medical-device list that reached 104 entries by February 2026, with most clearances using the 510(k) pathway and selected De Novo authorizations setting precedents, including AppliedVRs RelieVRx classification under 21 CFR 890.5800. As VR moves deeper into clinical workflows, the FDA also folded updated human-factors expectations into its submission tooling by integrating Human Factors Content Guidance (published May 29, 2026, effective August 1, 2026) into eSTAR templates, reinforcing usability, labeling, and use-environment considerations for immersive devices.
Outside the United States, developers and providers face parallel compliance pressure from privacy and device-safety regimes, which is pushing more formal evidence, risk management, and data-governance practices across deployments. Europe operates under GDPR-aligned data protections and medical-device oversight, while global regulators are also exploring controlled innovation approaches; regulatory sandbox concepts for emerging technologies have been discussed in multiple jurisdictions alongside conventional MDR/IVDR and digital-health pathways. In Canada, Health Canada signaled further tightening of establishment-level controls by modernizing Medical Device Establishment Licensing requirements through an updated GUI-0016 guidance slated to take effect on December 14, 2026, which changes how suppliers, importers, and distributors operationalize compliance for VR-enabled medical offerings.
Value Chain Analysis
The VR-in-healthcare value chain starts with enabling hardware and platforms (head-mounted displays, sensors, compute, and operating ecosystems) and extends through medical-grade integration, clinical content creation, and regulated deployment. Consumer and enterprise spatial-computing platforms supply the baseline device layer, while healthcare OEMs and workflow vendors translate clinical data into immersive visualizations and applications. For example, Siemens Healthineers positions 3D/VR visualization capabilities across offerings such as Cinematic Reality and planning tools.
These upstream layers are complemented by accessory and hygiene components, device-management tooling, and connectivity and security architectures that allow VR to be used in hospitals, clinics, and remote care settings. Midstream and downstream, specialized software developers and training-content providers build procedure libraries, rehabilitation modules, and analytics dashboards, often partnering with imaging or interventional system vendors to embed VR into established clinical pathways. A representative example is Siemens Healthineers partnership with PrecisionOS to develop VR-based surgical training tied to the Cios Spin mobile 3D C-arm, illustrating how OEM installed bases become distribution channels for VR content. Implementation and services complete the chain, covering clinical validation support, IT provisioning, cybersecurity and privacy controls, EHR and imaging system integration, and ongoing content updates, with hospitals and academic centers serving as co-development and evidence-generation nodes that can speed broader procurement and reimbursement acceptance.
Competitive Landscape
The Virtual Reality in Healthcare market remains moderately fragmented, with no single firm exceeding a one-quarter share. AppliedVR set a regulatory benchmark by obtaining FDA authorization for RelieVRx and then secured the first commercial-payer coverage with Highmark, catalyzing confidence among hospital buyers. Technology majors such as Apple and Meta supply high-volume headsets but rely on healthcare specialists for clinical content and regulatory dossiers. Osso VR, XRHealth, and Fundamental Surgery differentiate through evidence-backed libraries and cloud analytics that track performance at scale.
Strategic alliances are prolific. GE Healthcare and MediView co-develop augmented-reality guidance for interventional radiology, while pharmaceutical sponsors underwrite procedure-specific training modules bundled with drug launches. Venture capital continues to flow, focusing on start-ups with strong clinical-trial pipelines and reimbursement strategies. Intellectual-property portfolios increasingly combine device patents with health-economic data packages, an emerging requirement as payers demand proof of cost offsets.
Virtual Reality In Healthcare Industry Leaders
Koninklijke Philips N.V.
Samsung Electronics Co. Ltd.
HTC Corporation
Sony Corporation
Siemens Healthineers
- *Disclaimer: Major Players sorted in no particular order

Virtual Reality In Healthcare Market Companies Covered in this Report
- Microsoft
- Meta Platforms, Inc.
- HTC
- Sony Group
- Siemens Healthineers
- GE HealthCare Technologies Inc.
- Osso VR, Inc.
- Surgical Theater, Inc.
- MindMaze SA
- XRHealth USA, Inc.
- AppliedVR, Inc.
- Medical Realities Ltd.
- SyncThink, Inc.
- Vicarious Surgical, Inc.
- ImmersiveTouch, Inc.
- Samsung Group
- VirtaMed
- CAE
- FundamentalVR Ltd.
- BehaVR, LLC
Market Opportunities and Future Outlook
A gap is forming around regulated, evidence-backed VR workflows that sit adjacent to existing reimbursed care pathways, particularly where immersive therapy or training can be measured and documented. The FDA-listed AR/VR device footprint reached 104 entries by early 2026, indicating a wider pool of products and indications that providers and payers can reference when assessing procurement, safety, and clinical validity. This expansion aligns with the report's shift toward content-rich software platforms that scale through subscriptions and analytics, particularly in pain management, behavioral health, and rehabilitation, where outcomes tracking supports credentialing, quality reporting, and reimbursement documentation.
Another near-term opportunity is convergence of VR with imaging, planning, and hospital workflow design, which broadens use beyond episodic therapy into system-level efficiency and patient experience. Siemens Healthineers use of Apple Vision Pro for Cinematic Reality shows how spatial computing is packaged for surgical planning, medical education, and patient visualization, while Philips use of VR/AR-oriented suite planning tools (including SitePlanner and related visualization modules) points to demand from hospitals looking to validate layouts and workflows before construction or renovation. Partnerships that connect OEM clinical assets with specialist content libraries, such as Siemens Healthineers and PrecisionOS for VR training, create a route to scale across installed equipment fleets. They also support service providers delivering cybersecurity, device management, and integration bundles that can reduce deployment friction for hospitals, clinics, and rehabilitation centers.
Recent Industry Developments in Virtual Reality In Healthcare Market
- June 2026: Samsung partnered with clinical research organization Alcedis to advance clinical research using wearable-based endpoints. The collaboration targets translation of wearable-collected biometrics into evidence suitable for clinical trials, strengthening the data foundation that immersive and digital interventions can rely on when pursuing validation and adoption.
- May 2026: Philips integrated Disney storytelling content into its Ambient Experience for MRI across medical facilities in 87 countries. By combining immersive audiovisual environments with imaging workflows, the initiative positions VR-like patient-experience design as a mainstream lever for reducing anxiety and improving cooperation during diagnostic procedures.
- October 2024: HTC VIVE and Virtualware partnered to accelerate enterprise XR adoption, with HTC VIVE becoming an official distributor of Virtualwares VIROO Enterprise XR software platform in North America. The deal supports broader deployment of managed XR software stacks for multi-user training and simulation, capabilities that healthcare providers use for standardized clinical education and skills labs.
Virtual Reality In Healthcare Market Report Scope and Research Methodology
Market Definition and Coverage
For this study, the market covers revenues generated from using virtual reality solutions in healthcare settings, including VR hardware, VR software, and related services used for clinical and non-clinical medical workflows.
Scope exclusions: Non-immersive 2D simulation tools, augmented reality or mixed reality products sold without VR use cases, and general consumer VR spending not tied to healthcare applications are excluded.
Segments Covered in This Report
- By Component (Value, USD bn)
- Hardware
- Devices
- Head-Mounted Displays
- Gesture-Tracking Devices
- Projectors & Display Walls
- Other Devices
- Accessories
- Devices
- Software
- Services
- Hardware
- By Application (Value, USD bn)
- Surgery Simulation & Training
- Pain Management & PTSD
- Rehabilitation & Physical Therapy
- Medical Education & Training
- Patient Care Management
- Other Applications
- By End-User (Value, USD bn)
- Hospitals & Clinics
- Academic & Research Institutes
- Rehabilitation Centers
- Diagnostic Centers
- Other End-Users
- By Delivery Mode (Value, USD bn)
- Immersive VR
- Semi-Immersive VR
- Non-Immersive VR
- By Geography (Value, USD bn)
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- North America
Data Sources, Market Sizing, and Validation
Desk Research
Desk research is used to build the initial structure of the market and to anchor assumptions that should not change based on a single interview. We review public sources such as the U.S. FDA device databases and safety communications, the Centers for Medicare and Medicaid Services coverage and payment references, and national health statistics sources such as CDC where relevant to pain, rehab, and mental health context.
We also track standards and evidence signals through sources such as peer-reviewed journals indexed on PubMed, clinical trial registries such as ClinicalTrials.gov, and health system and university publications tied to training and simulation. To connect adoption to business reality, we use company filings, investor presentations, and trusted news coverage, supported by paid subscriptions for company financials and intelligence, patent databases, and a shipment-level import export database where hardware flows help sanity-check unit movement. These examples are not exhaustive, and many other sources were referenced for data collection, validation, and research clarification.
Primary Interviews and Surveys
Primary work is used to validate what desk research cannot fully explain, especially real-world adoption, purchasing decision paths, and average selling price behavior across care settings. We speak with a mix of hospital and clinic decision makers, training and simulation users, and solution-side experts across major regions so the assumptions reflect differences in regulation, funding, and digital health maturity.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 29% | CXOs: 14% | APAC: 37% |
| Mid tier: 54% | Functional/Unit leaders: 35% | EMEA: 36% |
| Smaller Players: 17% | Managers: 51% | Americas: 27% |
Market-Sizing & Forecasting
Sizing starts with a top-down demand pool build that ties VR use in healthcare to where spending actually happens, and then it is shaped into value by component and use case. The demand pool is reconstructed using indicators such as the rate of VR-assisted training adoption in medical education, the growth of therapy and rehabilitation programs using immersive content, and the mix shift between hardware purchases and recurring software or service contracts.
To keep the model practical, a few input variables are tracked closely and updated when new evidence appears, including headset and accessory pricing trends, replacement and refresh cycles in institutional settings, deployment sizes per site, and the share of projects that move from pilot to routine use. Forecasting is done using scenario analysis supported by expert views on reimbursement direction, regulatory clarity, and budget cycles, and then refined with time-series checks when stable historical series exist. Results are corroborated with selective bottom-up approximations, such as sampled ASP times estimated unit deployments and channel checks, with gaps handled through conservative ranges that are tightened after follow-up interviews.
Data Validation & Update Cycle
Outputs are validated through triangulation across independent signals, and the numbers are re-checked when a component line item moves outside expected ranges. We compare results against proxy metrics like device shipment direction, healthcare digital spending cues, and the pace of published clinical evidence, and then anomalies are reviewed in a second analyst pass before sign-off.
Reports are refreshed annually, and interim updates are triggered when material events occur, such as major regulatory actions, reimbursement changes, or a clear shift in device pricing. Before delivery, a fresh validation pass is completed so clients receive an updated view that reflects the latest available inputs.
Mordor Intelligence's Healthcare Virtual Reality Market Size Compared With Other Published Estimates
Published market values for VR in healthcare can look far apart because the scope boundaries are not always the same, and even small differences in included technologies can quickly change totals. Differences also show up when one publisher treats services as a pass-through cost, uses a different currency timing, or projects faster adoption from pilots than what providers actually budget for.
Regulatory clearances, payer reimbursement signals, and real deployment patterns in hospitals and training programs are the checks that keep Mordor Intelligence's estimate tied to VR-only healthcare spending, rather than blended AR plus VR totals. Another gap driver is the year labeling, since some sources report 2024 or 2025 as their base, and some jump to 2026 as the first forecast year, which shifts the visible market level even before growth is applied.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 5.15 B (2025) | |
| Trade Journal A | USD 2.80 B (2024) | Often combines AR and VR under one total, and the base year sits earlier, which can understate VR-only healthcare revenues when hardware and software scaling is accelerating. |
| Independent Repository B | USD 10.44 B (2025) | Uses a broader interpretation of VR in healthcare that can pull in adjacent spending and aggressive adoption assumptions, which lifts the 2025 level beyond what provider budget cycles typically support. |
The spread mainly comes from what is counted as VR, which year is treated as the starting point, and how quickly pilots are assumed to convert into repeat purchases. By keeping the scope tied to VR use cases in healthcare and by cross-checking totals with real adoption and pricing signals, the model stays repeatable and easier to trace back to clear inputs.
Key Questions Answered in the Report
How large will spending on immersive therapeutic VR become by 2031?
Expenditure is expected to reach USD 20.99 billion, reflecting the projected growth trajectory of the Virtual Reality in Healthcare market.
Which segment is expanding fastest across virtual reality health applications?
Rehabilitation and physical therapy is advancing at a 28.96% CAGR, making it the fastest-growing use case.
Why are insurers beginning to reimburse VR treatments?
FDA authorization and new CMS HCPCS codes have established clinical legitimacy and billing pathways, lowering financial risk for payers.
What is driving Asia-Pacific´s rapid uptake of medical VR?
Regional electronics manufacturing, government funding for digital health, and large aging populations combine to push a 30.05% CAGR.
Which delivery mode shows the best clinical outcomes?
Immersive VR leads in both market share and documented therapeutic efficacy for pain, mental health, and motor-skill rehabilitation.
How are hospitals addressing VR-related data-privacy risks?
Health systems deploy zero-trust networks, dedicated VR subnets, and real-time anomaly detection to protect biometric and behavioral data.
Page last updated on:




